180 related articles for article (PubMed ID: 12521401)
1. Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women.
Ahijevych KL; Tyndale RF; Dhatt RK; Weed HG; Browning KK
Nicotine Tob Res; 2002 Nov; 4(4):423-31. PubMed ID: 12521401
[TBL] [Abstract][Full Text] [Related]
2. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS
Trials; 2011 Jan; 12():22. PubMed ID: 21266057
[TBL] [Abstract][Full Text] [Related]
3. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
4. Comparative American and Japanese tobacco smoke uptake parameters after overnight tobacco deprivation.
Domino EF; Kadoya C; Matsuoka S; Ni L; Fedewa KS
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):973-84. PubMed ID: 14499314
[TBL] [Abstract][Full Text] [Related]
5. The influence of gender, race, and menthol content on tobacco exposure measures.
Mustonen TK; Spencer SM; Hoskinson RA; Sachs DP; Garvey AJ
Nicotine Tob Res; 2005 Aug; 7(4):581-90. PubMed ID: 16085529
[TBL] [Abstract][Full Text] [Related]
6. CYP2A6 genotype but not age determines cotinine half-life in infants and children.
Dempsey DA; Sambol NC; Jacob P; Hoffmann E; Tyndale RF; Fuentes-Afflick E; Benowitz NL
Clin Pharmacol Ther; 2013 Sep; 94(3):400-6. PubMed ID: 23714690
[TBL] [Abstract][Full Text] [Related]
7. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
8. Utility and relationships of biomarkers of smoking in African-American light smokers.
Ho MK; Faseru B; Choi WS; Nollen NL; Mayo MS; Thomas JL; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3426-34. PubMed ID: 19959692
[TBL] [Abstract][Full Text] [Related]
9. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.
Nagano T; Shimizu M; Kiyotani K; Kamataki T; Takano R; Murayama N; Shono F; Yamazaki H
Int J Environ Res Public Health; 2010 Jul; 7(7):2953-64. PubMed ID: 20717551
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Benowitz NL
Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
[TBL] [Abstract][Full Text] [Related]
12. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.
Zhu AZ; Renner CC; Hatsukami DK; Swan GE; Lerman C; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):708-18. PubMed ID: 23371292
[TBL] [Abstract][Full Text] [Related]
13. A novel duplication type of CYP2A6 gene in African-American population.
Fukami T; Nakajima M; Yamanaka H; Fukushima Y; McLeod HL; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):515-20. PubMed ID: 17267622
[TBL] [Abstract][Full Text] [Related]
14. Smoke constituent exposure and stage of change in black and white women cigarette smokers.
Ahijevych K; Parsley LA
Addict Behav; 1999; 24(1):115-20. PubMed ID: 10189978
[TBL] [Abstract][Full Text] [Related]
15. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
Huang S; Cook DG; Hinks LJ; Chen XH; Ye S; Gilg JA; Jarvis MJ; Whincup PH; Day IN
Pharmacogenet Genomics; 2005 Dec; 15(12):839-50. PubMed ID: 16272956
[TBL] [Abstract][Full Text] [Related]
16. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
17. Race/ethnicity moderates the effect of prepartum menthol cigarette use on postpartum smoking abstinence.
Reitzel LR; Nguyen N; Cao Y; Vidrine JI; Daza P; Mullen PD; Velasquez MM; Li Y; Cinciripini PM; Cofta-Woerpel L; Wetter DW
Nicotine Tob Res; 2011 Dec; 13(12):1305-10. PubMed ID: 21622498
[TBL] [Abstract][Full Text] [Related]
18. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
Murphy SE; Sipe CJ; Choi K; Raddatz LM; Koopmeiners JS; Donny EC; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1093-1099. PubMed ID: 28264876
[No Abstract] [Full Text] [Related]
19. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
[TBL] [Abstract][Full Text] [Related]
20. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
Rao Y; Hoffmann E; Zia M; Bodin L; Zeman M; Sellers EM; Tyndale RF
Mol Pharmacol; 2000 Oct; 58(4):747-55. PubMed ID: 10999944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
